Together these data suggest that low serum levels of C3 and C4 may be uniquely useful in subcategorizing CVID patients at risk for non-infectious complications including AIE, cytopenias (AIHA), and NRH. The gene discussed is C4A; the disease is autoimmune hemolytic anemia.